GOVX:NASDAQ
Geovax Labs Inc
$0.23
arrow_downward
-1.47%(-0.0035) 1D
Oct 19, 3:05:10 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GOVX...
Open
$0.24
High
$0.24
Low
$0.23
Mkt. cap
2.12M
Avg. vol.
730.57K
Volume
114.85K
52-wk high
$15.25
52-wk low
$0.23
EPS
-$13.92
Beta
3.69
Shares outstanding
10.10M
No. of employees
19
Open
$0.24
High
$0.24
Low
$0.23
Mkt. cap
2.12M
Avg. vol.
730.57K
Volume
114.85K
52-wk high
$15.25
52-wk low
$0.23
EPS
-$13.92
Beta
3.69
Shares outstanding
10.10M
No. of employees
19
News stories
From web sources and news partners
TradingView
·
42 minutes ago
Broader S&P 500 set to outpace Mag 7 in earnings growth for first time since 2022
The Lufkin Daily News
·
54 minutes ago
Nasdaq climbs as chip and AI-linked stocks bounce back
ChartMill
·
1 hour ago
Most Active S&P 500 Stocks on Oct. 19
KuCoin
·
1 hour ago
The Dow finished last week up 0.7%. Most of the stock market
Profile
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia
About Geovax Labs Inc
CEODavid A. Dodd
Employees19
Founded1988
HeadquartersAtlanta, Georgia, United States
SectorBiotechnology
Websitegeovax.com